Aciclovir 800mg tablets

Land: Storbritannien

Språk: engelska

Källa: MHRA (Medicines & Healthcare Products Regulatory Agency)

Aktiva substanser:

Aciclovir

Tillgänglig från:

Crescent Pharma Ltd

ATC-kod:

J05AB01

INN (International namn):

Aciclovir

Dos:

800mg

Läkemedelsform:

Oral tablet

Administreringssätt:

Oral

Klass:

No Controlled Drug Status

Receptbelagda typ:

Valid as a prescribable product

Produktsammanfattning:

BNF: 05030201; GTIN: 5017123004148

Produktens egenskaper

SUMMARY OF PRODUCT CHARACTERISTICS
1
NAME OF THE MEDICINAL PRODUCT
Aciclovir 800 mg Tablets
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each tablet contains 800 mg of aciclovir
For the full list of excipients, see section 6.1.
3
PHARMACEUTICAL FORM
Tablet
White, oval, biconvex tablets, 19.3mm long with a score line on one
side.
The score line is not intended for breaking the tablet.
4
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Aciclovir tablets are indicated for the treatment of varicella
(chickenpox) and
herpes zoster (shingles) infections (excluding neonatal HSV and severe
HSV
infections in immunocompromised children).
Aciclovir 800mg Tablets are recommended for children over the age of
6.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
Posology
Dosage in adults
_Treatment of varicella and herpes zoster infections_: 800 mg of
aciclovir
should
be
taken
five
times
daily
at
approximately
four-hourly
intervals,
omitting the night time dose. Treatment should continue for seven
days.
In severely immunocompromised patients (e.g. after marrow transplant)
or in
patients with impaired absorption from the gut, consideration should
be given
to intravenous dosing.
Dosing should begin as early as possible after the start of an
infection:
Treatment of herpes zoster yields better results if initiated as soon
as possible
after the onset of the rash. Treatment of chickenpox in
immunocompetent
patients should begin within 24 hours after onset of the rash.
Dosage in children
_Treatment of varicella infection _
6 years and over: 800 mg acyclovir four times daily
Treatment should continue for five days.
No specific data are available on the treatment of herpes zoster
infections in
immunocompetent children.
For treatment of neonatal herpes virus infections, intravenous
acyclovir is
recommended.
Dosage in the elderly:
The possibility of renal impairment in the elderly must be considered
and the
dosage
should
be
adjusted
accordingly
(see
Dosage
in
renal
impairment
below).
Adequate hydration of elderly patients taking high oral doses of